Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES

Watchlist Manager
Advanced Enzyme Technologies Ltd Logo
Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES
Watchlist
Price: 356.65 INR -1.26% Market Closed
Market Cap: 39.9B INR
Have any thoughts about
Advanced Enzyme Technologies Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one ADVENZYMES stock under the Base Case scenario is 311.56 INR. Compared to the current market price of 356.65 INR, Advanced Enzyme Technologies Ltd is Overvalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ADVENZYMES Relative Value
Base Case
311.56 INR
Overvaluation 13%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.4
P/S
P/S
Price to Sales
6.4
vs History
34
vs Industry
8
Median 3Y
6.3
Median 5Y
6.4
Industry
1.5
Forward
5.5
More Details
29.1
P/E
P/E
Price to Earnings
29.1
vs History
34
vs Industry
23
Median 3Y
30.3
Median 5Y
29.2
Industry
21.7
Forward
23
More Details
28
P/OCF
P/OCF
Price to OCF
28
vs History
17
vs Industry
15
Median 3Y
26.6
Median 5Y
25.9
Industry
13
More Details
43.3
P/FCFE
P/FCFE
Price to FCFE
43.3
vs History
19
vs Industry
18
Median 3Y
39.8
Median 5Y
38.9
Industry
20.5
More Details
3
P/B
P/B
Price to Book Value
3
vs History
42
vs Industry
18
Median 3Y
2.9
Median 5Y
3
Industry
1.6
More Details
5.6
EV/S
EV/S
Enterprise Value to Sales
5.6
vs History
41
vs Industry
10
Median 3Y
5.6
Median 5Y
5.6
Industry
1.6
Forward
4.8
More Details
7.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.2
vs History
44
vs Industry
41
Median 3Y
7.5
Median 5Y
7.5
Industry
7.2
More Details
17.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.2
vs History
19
vs Industry
27
Median 3Y
17.1
Median 5Y
16.7
Industry
13.2
Forward
15.8
More Details
20.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.8
vs History
26
vs Industry
27
Median 3Y
21.1
Median 5Y
19.4
Industry
17.5
Forward
19.1
More Details
24.5
EV/OCF
EV/OCF
Enterprise Value to OCF
24.5
vs History
20
vs Industry
20
Median 3Y
23.3
Median 5Y
23.2
Industry
13.9
More Details
36.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
36.5
vs History
12
vs Industry
15
Median 3Y
32.5
Median 5Y
31
Industry
19.1
More Details
3.5
EV/IC
EV/IC
Enterprise Value to IC
3.5
vs History
44
vs Industry
10
Median 3Y
3.4
Median 5Y
3.5
Industry
1.3
More Details

Multiples Across Competitors

ADVENZYMES Competitors Multiples
Advanced Enzyme Technologies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES
39.9B INR 6.4 29.1 17.2 20.8
US
Sherwin-Williams Co
NYSE:SHW
86.3B USD 3.7 33.7 21.8 25.4
US
Ecolab Inc
NYSE:ECL
67.5B USD 4.3 33 21 28.7
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.1T JPY 4.1 19.7 8.7 11.5
CH
Givaudan SA
SIX:GIVN
36.5B CHF 5.1 35.4 24.7 31.6
US
Dupont De Nemours Inc
NYSE:DD
32.2B USD 2.6 40.3 12.6 21
CN
Wanhua Chemical Group Co Ltd
SSE:600309
232.7B CNY 1.2 15.3 16.7 16.7
US
PPG Industries Inc
NYSE:PPG
27.8B USD 1.5 18.7 11.4 14.1
CH
DSM-Firmenich AG
AEX:DSFIR
26.1B EUR 2.5 12.2 30.9 -60.5
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.2T INR 6.3 47.8 32.4 37.6
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES
Average EV/EBIT: 24.5
20.8
76%
0.3
US
Sherwin-Williams Co
NYSE:SHW
25.4
34%
0.7
US
Ecolab Inc
NYSE:ECL
28.7
52%
0.6
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
11.5
N/A N/A
CH
Givaudan SA
SIX:GIVN
31.6
44%
0.7
US
Dupont De Nemours Inc
NYSE:DD
21
83%
0.3
CN
Wanhua Chemical Group Co Ltd
SSE:600309
16.7
39%
0.4
US
PPG Industries Inc
NYSE:PPG
14.1
28%
0.5
CH
D
DSM-Firmenich AG
AEX:DSFIR
Negative Multiple: -60.5 N/A N/A
IN
Asian Paints Ltd
NSE:ASIANPAINT
37.6
5%
7.1
DK
Novozymes A/S
CSE:NZYM B
37.9
N/A N/A

See Also

Summary
ADVENZYMES intrinsic value, competitors valuation, and company profile.
DCF Valuation
ADVENZYMES stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ADVENZYMES stock valuation using valuation multiples.
Wall Street Estimates
ADVENZYMES price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ADVENZYMES stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.